The Food and Drug Administration ("FDA") finalized its guidance on how manufacturers of certain drug products should present quantitative efficacy and risk information in promotion directed to ...
The US Food and Drug Administration (FDA) has finalized a revised draft guidance from 2022 on what human factors (HF) information sponsors should include in premarket submissions for medical devices.
At the beginning of December, the Information Regulator published the much-anticipated Guidance Note on Direct Marketing (Guidance Note) in terms of the Protection of Personal Information Act 2013 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results